Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | FNTA | P49354 | 2/20 | 0.45 |
| ▸ | FNTB | P49356 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.44 |
| ▸ | SQLE | Q14534 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL157735 | 0.95 | — | — | |
| SCHEMBL28009409 | 0.95 | KDM4E (0.62) | KDM4EATMPOLBKMT2ATSHR | |
| Bicarbonate SCHEMBL28331616 | 0.90 | KDM4E (0.64) | KDM4EATMPOLBKMT2ATSHR | |
| Hydrazine SCHEMBL17870970 | 0.90 | POLB (0.61) | KDM4EATMPOLBKMT2ATSHR | |
| Formic Acid SCHEMBL28331617 | 0.87 | KDM4E (0.56) | KDM4EATMPOLBKMT2ATSHR | |
| SCHEMBL14236831 | 0.85 | KMT2A (0.73) | KDM4EATMPOLBKMT2AALDH1A1 | |
| SCHEMBL3111482 | 0.85 | KMT2A (0.73) | KDM4EATMPOLBKMT2AALDH1A1 | |
| SCHEMBL790270 | 0.85 | KMT2A (0.73) | KDM4EATMPOLBKMT2AALDH1A1 | |
| SCHEMBL7946216 | 0.85 | KMT2A (0.73) | KDM4EATMPOLBKMT2AALDH1A1 | |
| SCHEMBL14236792 | 0.85 | KMT2A (0.73) | KDM4EATMPOLBKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019050803-A1 | SYSTEMS AND METHODS FOR COPPER ETCH RATE MONITORING AND CONTROL | UNIVERSITY OF NORTH TEXAS (US) | 2019-03-14 | — | — | WO | disclosed |
| EP-2975934-A1 | BLENDS AND THEIR USE IN THE CONTROLLING AND/OR TRAPPING OF MOTHS | Bioforsk (NO) | 2016-01-27 | — | — | EP | disclosed |
| WO-2014147110-A1 | BLENDS AND THEIR USE IN THE CONTROLLING AND/OR TRAPPING OF MOTHS | BIOFORSK (THE NORWEGIAN INSTITUTE FOR AGRICULTURAL AND ENVIRONMENTAL RESEARCH) (NO) | 2014-09-25 | — | — | WO | disclosed |
| US-7638658-B2 | Ethynylation process | DSM IP ASSETS B.V. (NL) | 2009-12-29 | — | — | US | disclosed |
| EP-1532092-B1 | ETHINYLATION PROCESS | DSM IP ASSETS BV (NL) | 2008-11-05 | — | — | EP | disclosed |
| EP-1432667-B1 | ETHYNYLATION PROCESS | DSM IP ASSETS BV (NL) | 2007-11-28 | — | — | EP | disclosed |
| US-20050240066-A1 | Ethynylation process | DSM IP ASSETS B.V. (NL) | 2005-10-27 | — | — | US | disclosed |
| US-6949685-B2 | reacting formaldehydes, acyclic aldehydes or ketones with acetylene in the presence of ammonia and ion exchange resins, to form acyclic unsaturated alcohols used as intermediates for vitamins and carotenoids; alkylynation | DSM IP ASSETS B.V. (NL) | 2005-09-27 | — | — | US | disclosed |
| EP-1532092-A1 | ETHYNYLATION PROCESS | DSM IP Assets B.V. (NL) | 2005-05-25 | — | — | EP | disclosed |
| US-20050059844-A1 | Ethynylation process | DSM IP ASSETS B.V. (NL) | 2005-03-17 | — | — | US | disclosed |
| EP-1432667-A1 | ETHYNYLATION PROCESS | DSM IP Assets B.V. (NL) | 2004-06-30 | — | — | EP | disclosed |
| WO-2004018400-A1 | ETHYNYLATION PROCESS | DSM IP ASSETS B.V. (NL) | 2004-03-04 | — | — | WO | disclosed |
| WO-2003029175-A1 | ETHYNYLATION PROCESS | DSM IP ASSETS B.V. (NL) | 2003-04-10 | — | — | WO | disclosed |
| US-6307106-B1 | REACTING THE CORRESPONDING ALPHA,BETA-UNSATURATED ALCOHOLS WITH ALKYL ACETOACETATES IN A CARROLL REACTION IN THE PRESENCE OF AN ORGANIC ALUMINUM COMPOUND AS CATALYST WITH CONTINUOUS REMOVAL BY DISTILLATION OF THE ALKANOL ELIMINATED | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240066-A1 | Ethynylation process | ADH1A, ADH4, ADH1C | KDM4E 2441/4885ATM 1252/4885POLB 856/4885 |
| US-20050059844-A1 | Ethynylation process | F12, CPS1, TTPA | KDM4E 932/4885ATM 734/4885POLB 849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.